Greenlane Holdings Inc. Renews Distribution Partnership with PAX to Expand Access to Award-Winning Cannabis Vaporizers

Reuters
04 Jun
<a href="https://laohu8.com/S/GNLN">Greenlane Holdings Inc.</a> Renews Distribution Partnership with PAX to Expand Access to Award-Winning Cannabis Vaporizers

Greenlane Holdings Inc. has renewed its distribution agreement with PAX, a leader in cannabis vaporization technologies. This collaboration ensures that PAX's award-winning portable dry herb vaporizers, including the PAX MINI and PAX PLUS, remain widely accessible throughout the U.S. via Greenlane's extensive distribution network. The partnership aims to expand product access in key markets, leveraging Greenlane's strong retail connections and operational scale. Both companies share a commitment to high-quality products and a consumer-focused approach in the growing cannabis industry.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Greenlane Holdings Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 1035232) on June 04, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10